In: Current Treatment Options in Oncology, 2015, vol. 16, no. 9, p. 1-13
|
In: Seminars in Immunopathology, 2015, vol. 37, no. 2, p. 173-186
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 12, p. 3599-3606
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 7, p. 1755-1758
|
In: Journal of Antimicrobial Chemotherapy, 2018, vol. 73, no. 12, p. 3413-3422
|
In: Toxicological Sciences, 2017, vol. 157, no. 1, p. 183-195
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 7, p. 1933-1942
|
In: PLoS pathogens, 2015, vol. 11, no. 10, p. e1005164
Candida spp. can cause severe and chronic mucocutaneous and systemic infections in immunocompromised individuals. Protection from mucocutaneous candidiasis depends on T helper cells, in particular those secreting IL-17. The events regulating T cell activation and differentiation toward effector fates in response to fungal invasion in different tissues are poorly understood. Here we generated...
|
In: European Journal of Clinical Pharmacology, 2014, vol. 70, no. 7, p. 829-837
|
In: Intensive Care Medicine, 2014, vol. 40, no. 10, p. 1429-1448
|